panel of experts - scdm 2020 annual conference | clinical ... · the panel • jonathan andrus...
TRANSCRIPT
![Page 1: Panel of Experts - SCDM 2020 Annual Conference | Clinical ... · The Panel • Jonathan Andrus M.S., CQA, CCDM • Chief Business Officer, Clinical Ink • Lisbeth Bregnhoj MScPharmacy,](https://reader035.vdocuments.us/reader035/viewer/2022070905/5f75d8466496dd6a6046aaca/html5/thumbnails/1.jpg)
![Page 2: Panel of Experts - SCDM 2020 Annual Conference | Clinical ... · The Panel • Jonathan Andrus M.S., CQA, CCDM • Chief Business Officer, Clinical Ink • Lisbeth Bregnhoj MScPharmacy,](https://reader035.vdocuments.us/reader035/viewer/2022070905/5f75d8466496dd6a6046aaca/html5/thumbnails/2.jpg)
Panel of ExpertsAn Anchor Plenary Session
02 October 2019
![Page 3: Panel of Experts - SCDM 2020 Annual Conference | Clinical ... · The Panel • Jonathan Andrus M.S., CQA, CCDM • Chief Business Officer, Clinical Ink • Lisbeth Bregnhoj MScPharmacy,](https://reader035.vdocuments.us/reader035/viewer/2022070905/5f75d8466496dd6a6046aaca/html5/thumbnails/3.jpg)
The Panel• Jonathan Andrus M.S., CQA, CCDM
• Chief Business Officer, Clinical Ink
• Lisbeth Bregnhoj MSc Pharmacy, PhD
• Medicines Inspector, GCP and GVP, Danish Health and Medicines Authority
• Jennifer Duff
• Managing Director and Global R&D Operations Lead, Accenture
• Ni Aye Khin, M.D.
• Director of Division of Clinical Compliance Evaluation, OSI, OoC, CDER at FDA
• Patrick Nadolny M.S.
• Associate VP, Clinical Data Management and Programming, Allergan
• Francois Torche, MBA
• CEO, CluePoints
• Joshua Wilson
• Exec. Director, CDS Strategic Technology Advancement Team, Syneos Health
• Demetris N. Zambas
• VP and Global Head of Data Monitoring and Management, Pfizer
![Page 4: Panel of Experts - SCDM 2020 Annual Conference | Clinical ... · The Panel • Jonathan Andrus M.S., CQA, CCDM • Chief Business Officer, Clinical Ink • Lisbeth Bregnhoj MScPharmacy,](https://reader035.vdocuments.us/reader035/viewer/2022070905/5f75d8466496dd6a6046aaca/html5/thumbnails/4.jpg)
https://scdm.org/publications/white-papers/
EVOLUTION OF CDM
4
![Page 5: Panel of Experts - SCDM 2020 Annual Conference | Clinical ... · The Panel • Jonathan Andrus M.S., CQA, CCDM • Chief Business Officer, Clinical Ink • Lisbeth Bregnhoj MScPharmacy,](https://reader035.vdocuments.us/reader035/viewer/2022070905/5f75d8466496dd6a6046aaca/html5/thumbnails/5.jpg)
Discussion Points
• Perspectives on the rising complexities of trial designs and
how they are impacting the discipline – Patrick and Joshua
• Summary on your perspectives on the evolving regulatory
environments and how they are impacting the discipline - Ni
and Lisbeth
• Summary on your perspectives of the technology
environments and how they are impacting the discipline -
Jonathan and Francois
• Summary on our perspectives on the impacts of the above on
the role of a DM - Jennifer and Demetris
![Page 6: Panel of Experts - SCDM 2020 Annual Conference | Clinical ... · The Panel • Jonathan Andrus M.S., CQA, CCDM • Chief Business Officer, Clinical Ink • Lisbeth Bregnhoj MScPharmacy,](https://reader035.vdocuments.us/reader035/viewer/2022070905/5f75d8466496dd6a6046aaca/html5/thumbnails/6.jpg)
Deep Dive with Audience
• What does the audience feel are the most significant threats
from the ecosystem and our weaknesses across the
roles/environment – panel commentary
• What does the audience feel are our most significant
opportunities and greatest strengths to enable us to not only
adopt but drive the evolution – panel commentary